Abstract
To date, more than seven families have been reported who carry a mutation in the X-linked creatine-transporter (CrT) gene. The resulting lack of creatine in the brain is associated with mental retardation, severe expressive language disorder, mild epilepsy, and a complete absence of Cr in the brain (measured using MRS). Conversely, these patients had no observable cardiac or musculo-skeletal deficits.
In this case study, a 22-year-old patient underwent surgical repair for scoliosis. Proton MRS of this patient's brain demonstrated the near-absence of creatine and phosphocreatine within the cerebral white and deep gray matter structures. Cerebral atrophy was noted with serial MRI examinations. Subsequent genetic and metabolic analysis showed some biochemical anomalies consistent with a CrT deficiency. The mutation in this patient was identified as a deletion at phenylalanine 107 (delF107). Control muscle biopsies were obtained from archived samples, which had been taken with informed consent during routine muscle biopsies for diagnostic purposes. We determined that the total Cr concentration in the skeletal muscle biopsy was 39.3 ± 2.94 mmol/kg wet wt., which is not significantly different from non-CrT controls, n= 3 (43.3 ± 3.57 mmol/kg wet wt.).
We conclude that the brain appears to lack the ability to transport creatine when there is a mutation in the CrT gene. However, the muscle utilizes another mechanism for maintaining normal creatine levels. Identifying this alternative creatine-transport mechanism may be useful in treating the neurologic and cognitive impairments of patients with creatine-transporter deficiency. (Mol Cell Biochem 262: 35–39, 2004)
Similar content being viewed by others
References
Cecil KM, Salomons GS, Ball WS, Jr, Wong B, Chuck G, Verhoeven NM, Jakobs C, DeGrauw TJ: Irreversible brain creatine deficiency with elevated serum and urine creatine: A creatine transporter defect? Ann Neurol 49: 401–404, 2001
Cecil KM, DeGrauw TJ, Salomons GS, Jakobs C, Egelhoff JC, Clark JF: Magnetic resonance spectroscopy in a 9-day-old heterozygous female child with creatine transporter deficiency. J Comput Assist Tomogr 27: 44–47, 2003
DeGrauw TJ, Salomons GS, Cecil KM, Chuck G, Newmeyer A, Schapiro MB, Jakobs C: Congenital creatine transporter deficiency. Neuropediatrics 33: 232–238, 2002
Salomons GS, van Dooren SJ, Verhoeven NM, Cecil KM, Ball WS, Degrauw TJ, Jakobs C: X-linked creatine-transporter gene (SLC6A8) defect: A new creatine-deficiency syndrome. Am J Hum Genet 68: 1497–1500, 2001
Hahn KA, Salomons GS, Tackels-Horne D, Wood TC, Taylor HA, Schroer RJ, Lubs HA, Jakobs C, Olson RL, Holden KR, Stevenson RE, Schwartz CE: X-linked mental retardation with seizures and carrier manifestations is caused by a mutation in the creatine-transporter gene (SLC6A8) located in Xq28. Am J Hum Genet 70: 5, 2002
Bizzi A, Bugiani M, Salomons GS, Hunneman DH, Moroni I, Estienne M, Danesi U, Jakobs C, Uziel G: X-linked creatine deficiency syndrome: Anovel mutation in creatine transporter gene SLC6A8. Ann Neurol 52: 227–231, 2002
de Grauw TJ, Cecil KM, Byars AW, Salomons GS, Ball WS, Jakobs C: The clinical syndrome of creatine transporter deficiency. Mol Cell Biochem 244: 45–48, 2003
Conn R: Fluorometric determination of creatine. Clin Chem 6:537–548, 1960
Das AM, Ullrich K, Isbrandt D: Upregulation of respiratory chain enzymes in guanidinoacetate methyltransferase deficiency. J Inherit Metab Disord 23: 375–377, 2000
Watchko JF, Daood MJ, Wieringa B, Koretsky AP: Myofibrillar or mitochondrial creatine kinase deficiency alone does not impair mouse diaphragm isotonic function. J Appl Physiol 88: 973–980, 2000
Braissant O, Henry H, Loup M, Eilers B, Bachmann C: Endogenous synthesis and transport of creatine in the rat brain: An in situ hybridization study. Brain Res Mol Brain Res 86: 193–201, 2001
Lee H, Kim JH, Chae YJ, Ogawa H, Lee MH, Gerton GL: Creatine synthesis and transport systems in the male rat reproductive tract. Biol Reprod 58: 1437–1444, 1998
Daly MM: Guanidinoacetate methyltransferase activity in tissues and cultured cells. Arch Biochem Biophys 236: 576–584, 1985
Robinson TM, Sewell DA, Casey A, Steenge G, Greenhaff PL: Dietary creatine supplementation does not affect some haematological indices, or indices of muscle damage and hepatic and renal function. Br J Sports Med 34: 284–288, 2000
Casey A, Greenhaff PL: Does dietary creatine supplementation play a role in skeletal muscle metabolism and performance? Am J Clin Nutr72(suppl 2): 607S–617S, 2000
Greenhaff PL: Creatine and its application as an ergogenic aid. Int J Sport Nutr 5: S100–S110, 1995
Happe HK, Murrin LC: In situ hybridization analysis of CHOT1, a creatine transporter, in the rat central nervous system. J Comp Neurol 351: 94–103, 1995
Schloss P, Mayser W, Betz H: The putative rat choline transporter CHOT1 transports creatine and is highly expressed in neural and musclerich tissues. Biochem Biophys Res Commun 198: 637–645, 1994
Iyengar MR: Creatine kinase as an intracellular regulator. J Muscle Res Cell Motil 5: 527–534, 1984
Ishida Y, Riesinger I, Wallimann T, Paul RJ: Compartmentation of ATP synthesis and utilization in smooth muscle: Roles of aerobic glycolysis and creatine kinase. Mol Cell Biochem 133–134: 39–50, 1994
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pyne-Geithman, G.J., deGrauw, T.J., Cecil, K.M. et al. Presence of normal creatine in the muscle of a patient with a mutation in the creatine transporter: A case study. Mol Cell Biochem 262, 35–39 (2004). https://doi.org/10.1023/B:MCBI.0000038213.15646.4a
Issue Date:
DOI: https://doi.org/10.1023/B:MCBI.0000038213.15646.4a